HOME >> BIOLOGY >> NEWS
Other highlights in the Jan. 17 JNCI

Calcium Supplements Offer Prolonged Protection Against Colorectal Adenomas in High-Risk Patients

Previous studies have shown that people with noncancerous colorectal tumors called adenomas who take calcium supplements for 4 years can reduce their risk of an adenoma recurrence. A new study shows that the protective effect of those supplements lasts for up to 5 years after stopping supplementation.

In the Calcium Polyp Prevention Study, 930 people with a recent adenoma were randomly assigned to receive 4 years of daily 1200-milligram calcium supplements or a placebo. The study revealed that those assigned to calcium supplements had a 17 percent lower relative risk of an adenoma recurrence than those who got the placebo.

In the new study, Maria V. Grau, M.D., and John A. Baron, M.D., of Dartmouth Medical School, and colleagues followed 822 of the patients from that trial after the end of the treatment. Their aim was to compare the risk of recurrence among participants who had taken calcium with the risk among those who had taken a placebo.

The researchers found that, in the first 5 years after the end of the treatment, people in the calcium group continued to have a lower risk of adenomas than those in the placebo group: 31.5 percent of people who had taken calcium had recurrences compared with 43.2 percent of those originally in the placebo group. However, after 5 years, this protective effect disappeared.

"Our study provides further evidence of the potential of calcium as a chemopreventive agent against colorectal adenomas among individuals with a history of these tumors," the authors write. "Our data indicate that, in these patients, the protective effect of calcium may extend for up to 5 years after the cessation of active treatment."

"Where do we go from here--and, more important, what public health recommendations related to calcium do we provide for risk reduction of colorectal cancer?" ask ed
'"/>

Contact: Andrea Widener
jncimedia@oxfordjournals.org
301-841-1287
Journal of the National Cancer Institute
16-Jan-2007


Page: 1 2 3 4 5 6 7

Related biology news :

1. Other highlights in the Aug. 7 JNCI
2. Other highlights in the July 24 JNCI
3. Other highlights from the July 10 JNCI
4. Other highlights in JNCI, June 26
5. Other highlights in JNCI, June 12
6. Other highlights from the June 6 JNCI
7. Other highlights in the May 16 JNCI
8. Other highlights from the April 18 Journal of the National Cancer Institute
9. Other highlights from the March 21 JNCI
10. Other highlights in the March 7 JNCI
11. Other highlights in the Feb. 21 JNCI

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:3/9/2019)... ... March 09, 2019 , ... Hello Bio announces the launch ... for scientists studying GPCR and DREADD signalling. Hello Bio has been granted a ... Neurological Disorders and Stroke, both institutes of the National Institutes of Health, as ...
(Date:3/1/2019)... ... March 01, 2019 , ... Geneious would like to announce it ... alternative to Vector NTI. , Geneious Prime already has a dedicated importer for ... NTI, so that files will be organised in Geneious in the same way. ...
(Date:2/27/2019)... ... February 27, 2019 , ... Fluxion Biosciences, a leading developer of precision solutions ... Cancer Institute grant for further development of its ERASE-Seq liquid biopsy technology. The Phase ... lab of Dr. Omar Mian at the Cleveland Clinic. , Liquid biopsies offer the ...
Breaking Biology News(10 mins):
(Date:3/14/2019)... ... March 14, 2019 , ... EyeCRO LLC has been awarded ... joins the Department of Veterans Affairs, the Oklahoma Medical Research Foundation, Oklahoma State ... in Oklahoma to receive this prestigious endorsement. The award letter from AAALAC ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... that its Canadian partner, the Eye Machine Canada Inc., had been given approval ... technology for treating Age-Related Macular Degeneration (AMD). , The previous month, the medical ...
(Date:3/14/2019)... ... March 14, 2019 , ... ... for preclinical research organizations. It is a low code, GDPR/21 CFR Part ... facilities, innovative technology-driven automated data capture and seamless data and information management. ...
(Date:3/11/2019)... ... 11, 2019 , ... In this live webinar, the featured speakers will focus ... and experience. Participants will learn how to use the information they have from the ... simple or complex randomization scheme is properly designed and set up to ensure flawless ...
Breaking Biology Technology:
Cached News: